• By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.
In the last 7 days
Gilead Sciences to Present at Upcoming Investor Conferences Gilead Sciences (Press Release)21:10 20-Feb-24
Gilead signs antibody deal with Biocytogen amid ADC buzz Pharmaceutical Technology16:39 19-Feb-24
In the last month
Dragonfly and Gilead enter partnership for cancer therapy Pharmaceutical Technology11:01 16-Feb-24
Gilead plans $4.3 billion deal to advance liver portfolio European Pharmaceutical Review19:30 14-Feb-24
Gilead opens new inflammatory diseases research centre Pharmaceutical Field13:51 14-Feb-24
Gilead Sciences Acquire CymaBay Therapeutics for $4.3 Billion European Pharmaceutical Manufacturer09:55 13-Feb-24
Gilead to Acquire CymaBay for $4.3B, Adding to Liver Portfolio Genetic Engineering and Biotechnology News21:33 12-Feb-24
Gilead to acquire CymaBay for $4.3 billion Investing.com15:59 12-Feb-24
FDA puts Gilead’s magrolimab trials on clinical hold Clinical Trials Arena09:14 8-Feb-24
Why Gilead Sciences Stock Dropped Today The Motley Fool20:56 7-Feb-24
Gilead Sciences posts $5.61bn net income in FY 2023 Pharmaceutical Technology11:55 7-Feb-24
AHF Hammers Gilead Over Continued Profiteering Business Wire (Press Release)00:26 7-Feb-24
Ted Love, MD, Joins Gilead Sciences’ Board of Directors Gilead Sciences (Press Release)21:38 1-Feb-24
Arcus rises, Gilead slips on expanded agreement Proactive Investors (US)14:59 30-Jan-24
Gilead and Arcus Biosciences expand oncology partnership deal Pharmaceutical Technology09:47 30-Jan-24
view more headlines
24 Feb 10:59

Publication filters

Headline Density

Sorry, no headlines or news topics were found. Please try different keywords.